After a sharp drop early in the COVID-19 pandemic, rates of routine breast and colon cancer screening soon returned to near-normal levels, a new study finds.
After a sharp drop early in the COVID-19 pandemic, rates of routine breast and colon cancer screening soon returned to near-normal levels, a new study finds.
